ChartMill assigns a Buy % Consensus number of 86% to SIOX. The Buy consensus is the weighted average rating of the current analysts ratings.
| Date | Firm | Action | Rating |
|---|---|---|---|
| 2022-04-28 | Cantor Fitzgerald | Downgrade | Overweight -> Neutral |
| 2022-04-28 | HC Wainwright & Co. | Downgrade | Buy -> Sell |
| 2022-02-01 | SVB Leerink | Downgrade | Outperform -> Market Perform |
| 2022-02-01 | HC Wainwright & Co. | Maintains | Buy |
| 2021-10-21 | HC Wainwright & Co. | Maintains | Buy |
| 2021-08-12 | SVB Leerink | Maintains | Outperform |
| 2021-06-15 | BTIG | Initiate | Buy |
| 2021-04-30 | HC Wainwright & Co. | Initiate | Buy |
7 analysts have analysed SIOX and the average price target is 5.1 USD. This implies a price increase of 1128.92% is expected in the next year compared to the current price of 0.415.
The consensus rating for SIO GENE THERAPIES INC (SIOX) is 85.7143 / 100 . This indicates that analysts generally have a positive outlook on the stock.